|
UBE3B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2308000002802E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.92371999999663E-05 |
| Normal-vs-Stage2 |
7.92540000000841E-05 |
| Normal-vs-Stage3 |
2.0014999990714E-08 |
| Normal-vs-Stage4 |
3.81869999954709E-07 |
| Stage1-vs-Stage2 |
3.282000E-01 |
| Stage1-vs-Stage3 |
1.474290E-02 |
| Stage1-vs-Stage4 |
3.585900E-02 |
| Stage2-vs-Stage3 |
4.381200E-01 |
| Stage2-vs-Stage4 |
4.828800E-01 |
| Stage3-vs-Stage4 |
9.738400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.53079999787309E-08 |
| Normal-vs-AfricanAmerican |
2.363700E-03 |
| Normal-vs-Asian |
1.102420E-01 |
| Caucasian-vs-AfricanAmerican |
4.322600E-01 |
| Caucasian-vs-Asian |
6.496600E-01 |
| AfricanAmerican-vs-Asian |
8.930000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08710004834245E-09 |
| Normal-vs-Female |
1.631860E-04 |
| Male-vs-Female |
1.334340E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.597500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.01089999998894E-06 |
| Normal-vs-Age(61-80Yrs) |
2.01890000273153E-08 |
| Normal-vs-Age(81-100Yrs) |
1.594560E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.267600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.360600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.963600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.563190E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.438000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.483200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.229600E-01 |
| Normal-vs-Grade 2 |
4.34549999994704E-06 |
| Normal-vs-Grade 3 |
1.36540000417185E-08 |
| Normal-vs-Grade 4 |
1.57589996607754E-09 |
| Grade 1-vs-Grade 2 |
3.236400E-02 |
| Grade 1-vs-Grade 3 |
7.098800E-03 |
| Grade 1-vs-Grade 4 |
4.421300E-04 |
| Grade 2-vs-Grade 3 |
1.017640E-01 |
| Grade 2-vs-Grade 4 |
5.215800E-03 |
| Grade 3-vs-Grade 4 |
1.162390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.87549999997039E-06 |
| Normal-vs-ccB subtype |
4.13239999996762E-06 |
| ccA subtype-vs-ccB subtype |
7.974800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.76659999998152E-06 |
| Normal-vs-N1 |
1.571010E-01 |
| N0-vs-N1 |
7.478000E-01 |
|
|
